术前血糖控制与糖尿病患者冠脉搭桥术后长期生存
该研究基于退伍军人事务数据,分析糖尿病合并孤立性冠脉搭桥(CABG)患者术前糖化血红蛋白(HbA1c)与长期结局的关系。结果显示术前HbA1c>8%与死亡及不良心脏事件风险增加相关。
要点
- 术前HbA1c>8%与CABG术后远期死亡风险增加相关。
- HbA1c 8-10%及>10%与心肌梗死和再次血运重建风险增加相关。
- HbA1c>10%患者中76%术后血糖水平改善。
核心结论
- 在CABG患者中,术前HbA1c>8%与死亡及不良心脏事件风险增加相关。
主要发现
- 按HbA1c分组:<6.5%占19.4%,6.5-8%占45.4%,8-10%占27%,>10%占8.2%。
- HbA1c>10%组最年轻(平均年龄60.9岁),胰岛素依赖比例78%,76%患者术后HbA1c改善。
- 中位随访5.8(3.2-8.8)年,与总体平均HbA1c 7.3%相比,HbA1c>8%时死亡率增加,尤其术前HbA1c>9%时。
- 与HbA1c<8%相比,HbA1c 8-10%和>10%与心肌梗死风险增加相关(HR 1.24和HR 1.39)。
- 与HbA1c<8%相比,HbA1c 8-10%和>10%与再次干预需求增加相关(HR 1.20和HR 1.24)。
临床怎么用
- CABG术前应关注HbA1c水平,HbA1c>8%提示远期死亡及不良心脏事件风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We analysed the Veteran Affairs data to evaluate the association of pre-operative glycated haemoglobin (HbA1c) and long-term outcome after isolated coronary artery bypass grafting (CABG). METHODS: Veterans with diabetes mellitus and isolated CABG (2006-2018) were divided into 4 groups (I: HbA1c <6.5%, II: HbA1c 6.5-8, III 8-10% and IV: HbA1c >10%). The relationship of pre-operative HbA1c and long-term survival was evaluated with a multivariable Cox proportional hazards model and reported as hazard ratios (HR). The cumulative incidence of secondary end-points [myocardial infarction (MI) and repeat revascularization (percutaneous intervention)] for each group was modelled as competing events with cause-specific Cox proportional hazards models. RESULTS: Overall, 16 190 patients (mean age 64.9 years, male 98%; insulin dependent 53%) with diabetes mellitus underwent isolated CABG. We observed 19.4%, 45.4%, 27% and 8.2% patients in groups I, II, III and IV, respectively. Patients with HbA1c >10% were the youngest (mean age 60.9 years) and had high rates of Insulin dependence (78%). In patients with HbA1c >10%, improvement in levels was observed in 76%. The median follow-up observed was 5.8 (3.2-8.8) years. Compared to the study mean HbA1c (7.3%), mortality rate increased with HbA1c levels >8%, and especially with pre-operative HbA1c levels >9%. Compared to patients with HbA1c <8%, HbA1c 8-10% and >10% were associated with increased MI (HR 1.24 and HR 1.39, respectively) and need for reintervention (HR 1.20 and HR 1.24, respectively). CONCLUSIONS: In patients undergoing CABG, pre-operative HbA1c >8% is associated with the increased risk of mortality and adverse cardiac events.
引用
- Deo S, Sundaram V, Sheikh MA, et al. Pre-operative glycaemic control and long-term survival in diabetic patients after coronary artery bypass grafting. Eur J Cardiothorac Surg. 2021. PMID: 33970210. doi:10.1093/ejcts/ezab180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。